IM Cannabis Corp. (CSE:IMCC) shareholders won’t be pleased to see that the share price has had a very rough month, dropping 28% and undoing the prior period’s positive performance. The drop over the last 30 days has capped off a tough year for shareholders, with the share price down 45% in that time.
After such a large drop in price, IM Cannabis may be sending bullish signals at the moment with its price-to-sales (or “P/S”) ratio of 0.1x, since almost half of all companies in the Pharmaceuticals industry in Canada have P/S ratios greater than 1x and even P/S higher than 3x are not unusual. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the reduced P/S.
See our latest analysis for IM Cannabis
How Has IM Cannabis Performed Recently?
IM Cannabis hasn’t been tracking well recently as its declining revenue compares…
